|
1
|
Tye CE, Gordon JA, Martin-Buley LA, Stein
JL, Lian JB and Stein GS: Could lncRNAs be the missing links in
control of mesenchymal stem cell differentiation? J Cell Physiol.
230:526–534. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Vella LJ: The emerging role of exosomes in
epithelial-mesenchymal-transition in cancer. Fron Oncol.
4:3612014.
|
|
3
|
Xu Q, Deng F, Qin Y, Zhao Z, Wu Z, Xing Z,
Ji A and Wang QJ: Long non-coding RNA regulation of
epithelial-mesenchymal transition in cancer metastasis. Cell Death
Dis. 7:e22542016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Tan EJ, Olsson AK and Moustakas A:
Reprogramming during epithelial to mesenchymal transition under the
control of TGFβ. Cell Adh Migr. 9:233–246. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Hajjari M and Salavaty A: HOTAIR: An
oncogenic long non-coding RNA in different cancers. Cancer Biol
Med. 12:1–9. 2015.PubMed/NCBI
|
|
6
|
Gutschner T and Diederichs S: The
hallmarks of cancer: A long non-coding RNA point of view. RNA Biol.
9:703–719. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zhang J, Zhang P, Wang L, Piao HL and Ma
L: Long non-coding RNA HOTAIR in carcinogenesis and metastasis.
Acta Biochim Biophys Sin. 46:1–5. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Hurvitz SA, Dalenc F, Campone M, O'Regan
RM, Tjan-Heijnen VC, Gligorov J, Llombart A, Jhangiani H,
Mirshahidi HR, Tan-Chiu E and Miao S: A phase 2 study of everolimus
combined with trastuzumab and paclitaxel in patients with
HER2-overexpressing advanced breast cancer that progressed during
prior trastuzumab and taxane therapy. Breast Cancer Res Treat.
141:437–446. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Baselga J, Semiglazov V, van Dam P,
Manikhas A, Bellet M, Mayordomo J, Campone M, Kubista E, Greil R,
Bianchi GS, et al: Phase II randomized study of neoadjuvant
everolimus plus letrozole compared with placebo plus letrozole in
patients with estrogen receptor-positive breast cancer. J Clin
Oncol. 27:2630–2637. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ellard SL, Clemons M, Gelmon KA, Norris B,
Kennecke H, Chia S, Pritchard K, Eisen A, Vandenberg T, Taylor M,
et al: Randomized phase II study comparing two schedules of
everolimus in patients with recurrent/metastatic breast cancer:
NCIC Clinical Trials Group IND. 163. J Clin Oncol. 27:4536–4541.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Tomei P, Masola V, Granata S, Bellin G,
Carratù P, Ficial M, Ventura VA, Onisto M, Resta O, Gambaro G, et
al: Everolimus-induced epithelial to mesenchymal transition (EMT)
in bronchial/pulmonary cells: When the dosage does matter in
transplantation. J Nephrol. 29:881–891. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Masola V, Carraro A, Zaza G, Bellin G,
Montin U, Violi P, Lupo A and Tedeschi U: Epithelial to mesenchymal
transition in the liver field: The double face of Everolimus in
vitro. BMC Gastroenterol. 15:1182015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Mitchell PS, Parkin RK, Kroh EM, Fritz BR,
Wyman SK, Pogosova-Agadjanyan EL, Peterson A, Noteboom J, O'Briant
KC, Allen A, et al: Circulating microRNAs as stable blood-based
markers for cancer detection. Proc Natl Acad Sci USA.
105:10513–10518. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Franken NA, Rodermond HM, Stap J, Haveman
J and Van Bree C: Clonogenic assay of cells in vitro. Nat Protoc.
1:2315–2319. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Szklarczyk D, Franceschini A, Wyder S,
Forslund K, Heller D, Huerta-Cepas J, Simonovic M, Roth A, Santos
A, Tsafou KP, et al: STRING v10: Protein-protein interaction
networks, integrated over the tree of life. Nucleic Acids Res.
43((Database Issue)): D447–D452. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ribeiro AS and Paredes J: P-cadherin
linking breast cancer stem cells and invasion: A promising marker
to identify an ‘intermediate/metastable’ EMT state. Front Oncol.
4:3712014.PubMed/NCBI
|
|
18
|
Tryndyak VP, Beland FA and Pogribny IP:
E-cadherin transcriptional down-regulation by epigenetic and
microRNA-200 family alterations is related to mesenchymal and
drug-resistant phenotypes in human breast cancer cells. Int J
Cancer. 126:2575–2583. 2010.PubMed/NCBI
|
|
19
|
Pittenger MF, Mackay AM, Beck SC, Jaiswal
RK, Douglas R, Mosca JD, Moorman MA, Simonetti DW, Craig S and
Marshak DR: Multilineage potential of adult human mesenchymal stem
cells. Science. 284:143–147. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhang GJ, Zhou T, Tian HP, Liu ZL and Xia
SS: High expression of ZEB1 correlates with liver metastasis and
poor prognosis in colorectal cancer. Oncol Lett. 5:564–568. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Lamouille S, Xu J and Derynck R: Molecular
mechanisms of epithelial-mesenchymal transition. Nat Rev Mol Cell
Biol. 15:178–196. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wang MK, Sun HQ, Xiang YC, Jiang F, Su YP
and Zou ZM: Different roles of TGF-β in the multi-lineage
differentiation of stem cells. World J Stem Cells. 4:28–34. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Mao L, Li Y, Zhao J, Li Q, Yang B, Wang Y,
Zhu Z, Sun H and Zhai Z: Transforming growth factor-β1 contributes
to oxaliplatin resistance in colorectal cancer via epithelial to
mesenchymal transition. Oncol Lett. 14:647–654. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Vu T and Datta PK: Regulation of EMT in
colorectal cancer: A culprit in metastasis. Cancers. 9:1712017.
View Article : Google Scholar
|
|
25
|
Xu Q, Wang L, Li H, Han Q, Li J, Qu X,
Huang S and Zhao RC: Mesenchymal stem cells play a potential role
in regulating the establishment and maintenance of
epithelial-mesenchymal transition in MCF7 human breast cancer cells
by paracrine and induced autocrine TGF-β. Int J Oncol. 41:959–968.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Wang Y, Liu J, Ying X, Lin PC and Zhou BP:
Twist-mediated epithelial-mesenchymal transition promotes breast
tumor cell invasion via inhibition of hippo pathway. Sci Rep.
6:246062016. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Yusup A, Huji B, Fang C, Wang F, Dadihan
T, Wang HJ and Upur H: Expression of trefoil factors and TWIST1 in
colorectal cancer and their correlation with metastatic potential
and prognosis. World J Gastroenterol. 23:110–120. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Kim YH, Kim G, Kwon CI, Kim JW, Park PW
and Hahm KB: TWIST1 and SNAI1 as markers of poor prognosis in human
colorectal cancer are associated with the expression of ALDH1 and
TGF-β1. Oncol Rep. 31:1380–1388. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Gupta RA, Shah N, Wang KC, Kim J, Horlings
HM, Wong DJ, Tsai MC, Hung T, Argani P, Rinn JL, et al: Long
noncoding RNA HOTAIR reprograms chromatin state to promote cancer
metastasis. Nature. 464:1071–1076. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Breastcancer.org, . Triple-Negative Breast
Cancer. http://www.breastcancer.org/symptoms/diagnosis/trip_negOctober.
2017
|
|
31
|
Chacón RD and Costanzo MV: Triple-negative
breast cancer. Breast Cancer Res. 12 (Suppl 2):S32010. View Article : Google Scholar
|
|
32
|
Pádua Alves C, Fonseca AS, Muys BR, de
Barros E, Lima Bueno R, Bürger MC, de Souza JE, Valente V, Zago MA
and Silva WA Jr: Brief report: The lincRNA HOTAIR is required for
epithelial-to-mesenchymal transition and stemness maintenance of
cancer cell lines. Stem Cells. 31:2827–2832. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Amiri A, Noei F, Jeganathan S, Kulkarni G,
Pinke DE and Lee JM: eEF1A2 activates Akt and stimulates
Akt-dependent actin remodeling, invasion and migration. Oncogene.
26:3027–3040. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Puertollano R: mTOR and lysosome
regulation. F1000Prime Rep. 6:522014. View
Article : Google Scholar : PubMed/NCBI
|
|
35
|
Liang YJ, Wang QY, Zhou CX, Yin QQ, He M,
Yu XT, Cao DX, Chen GQ, He JR and Zhao Q: MiR-124 targets Slug to
regulate epithelial-mesenchymal transition and metastasis of breast
cancer. Carcinogenesis. 34:713–722. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Nieman MT, Prudoff RS, Johnson KR and
Wheelock MJ: N-cadherin promotes motility in human breast cancer
cells regardless of their E-cadherin expression. J Cell Biol.
147:631–144. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Chen BW, Chen W, Liang H, Liu H, Liang C,
Zhi X, Hu LQ, Yu XZ, Wei T, Ma T, et al: Inhibition of mTORC2
induces cell-cycle arrest and enhances the cytotoxicity of
doxorubicin by suppressing MDR1 expression in HCC cells. Molr
Cancer Ther. 14:1805–1815. 2015. View Article : Google Scholar
|
|
38
|
Zarzynska JM: Two faces of TGF-beta1 in
breast cancer. Mediators Inflamm. 2014:1417472014. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Browman G, Goldberg J, Gottlieb AJ,
Preisler HD, Azarnia N, Priore RL, Brennan JK, Vogler WR, Winton
EF, Miller KB, et al: The clonogenic assay as a reproducible in
vitro system to study predictive parameters of treatment outcome in
acute nonlymphoblastic leukemia. Am J Hematol. 15:227–235. 1983.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Reya T, Morrison SJ, Clarke MF and
Weissman IL: Stem cells, cancer, and cancer stem cells. Nature.
414:105–111. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Srinivasan B, Kolli AR, Esch MB, Abaci HE,
Shuler ML and Hickman JJ: TEER measurement techniques for in vitro
barrier model systems. J Lab Autom. 20:107–126. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Lin CW, Lin PY and Yang PC: Noncoding RNAs
in tumor epithelial-to-mesenchymal transition. Stem Cells Int.
2016:27327052016. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Kotiyal S and Bhattacharya S: Breast
cancer stem cells, EMT and therapeutic targets. Biochem Biophys Res
Commun. 453:112–116. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Kidd M, Schimmack S, Lawrence B, Alaimo D
and Modlin IM: EGFR/TGFα and TGFβ/CTGF signaling in neuroendocrine
neoplasia: Theoretical therapeutic targets. Neuroendocrinology.
97:35–44. 2013. View Article : Google Scholar : PubMed/NCBI
|
